We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

43 hedge funds and large institutions have $16.1M invested in Bio-Path Holdings Inc in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 48 → 43 (-5)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

40% less capital invested

Capital invested by funds: $26.7M → $16.1M (-$10.7M)

Holders
43
Holders Change
-5
Holders Change %
-10.42%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
12
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.5M
2
TRCT
Tower Research Capital (TRC)
New York
+$116K
3
HighTower Advisors
HighTower Advisors
Illinois
+$94.4K
4
State Street
State Street
Massachusetts
+$43.6K
5
Wells Fargo
Wells Fargo
California
+$36.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$229K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$155K
3
Morgan Stanley
Morgan Stanley
New York
-$127K
4
Citigroup
Citigroup
New York
-$79.9K
5
JP Morgan Chase
JP Morgan Chase
New York
-$54.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$49K -$54.5K -15 -50%
NFA
27
Nationwide Fund Advisors
Ohio
$43K – – –
AIG
28
American International Group
New York
$42K +$3.63K +1 +8%
VOYA Investment Management
29
VOYA Investment Management
Georgia
$37K – – –
IIC
30
Ironwood Investment Counsel
Arizona
$36K – – –
Legal & General Group
31
Legal & General Group
United Kingdom
$26K – – –
Deutsche Bank
32
Deutsche Bank
Germany
$18K -$25.4K -7 -54%
Principal Financial Group
33
Principal Financial Group
Iowa
$17K +$18.2K +5 New
Bank of America
34
Bank of America
North Carolina
$13K – – –
Goldman Sachs
35
Goldman Sachs
New York
$13K – – –
CS
36
Credit Suisse
Switzerland
$11K -$18.2K -5 -63%
GRP
37
Global Retirement Partners
California
$11K – – –
AB
38
Amalgamated Bank
New York
$9K – – –
ProShare Advisors
39
ProShare Advisors
Maryland
$8K -$3.63K -1 -25%
AIP
40
Ameritas Investment Partners
Nebraska
$5K +$7.26K +2 New
MAM
41
Meeder Asset Management
Ohio
$3K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$3K – – –
UBS Group
43
UBS Group
Switzerland
$2K -$10.9K -3 -75%
PAM
44
Panagora Asset Management
Massachusetts
$1K – – –
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$155K -29 Closed
Citigroup
46
Citigroup
New York
– -$79.9K -22 Closed
HSBC Holdings
47
HSBC Holdings
United Kingdom
– -$21K -4 Closed
VKH
48
Virtu KCG Holdings
New York
– -$20K -4 Closed
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
– -$1.07K – –
1
2

BPTH Hedge Fund Activity: Q1 2017 in Review

43 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2017, worth a combined $16.1M — down 40% from $26.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BPTH and 3 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 12 added.

The largest buyer was BlackRock, adding an estimated $3.5M. The largest seller was Millennium Management, cutting an estimated $229K.

  • 43 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2017, down from 48 in Q4 2016.
  • Funds reported $16.1M of Bio-Path Holdings Inc stock for Q1 2017, down 40% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q1 2017 and 4 closed out, a net change of -1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q1 2017 was BlackRock, an estimated $3.5M added.
  • The largest Bio-Path Holdings Inc seller in Q1 2017 was Millennium Management, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2017.